Cargando…

Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease

BACKGROUND: Increased protease activity is a key pathological feature of inflammatory bowel disease (IBD). However, the differences in extracellular matrix remodelling (ECM) in Crohn’s disease (CD) and ulcerative colitis (UC) are not well described. An increased understanding of the inflammatory pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortensen, Joachim Høg, Manon-Jensen, Tina, Jensen, Michael Dam, Hägglund, Per, Klinge, Lone Gabriels, Kjeldsen, Jens, Krag, Aleksander, Karsdal, Morten Asser, Bay-Jensen, Anne-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640222/
https://www.ncbi.nlm.nih.gov/pubmed/29028807
http://dx.doi.org/10.1371/journal.pone.0185855
_version_ 1783271009968717824
author Mortensen, Joachim Høg
Manon-Jensen, Tina
Jensen, Michael Dam
Hägglund, Per
Klinge, Lone Gabriels
Kjeldsen, Jens
Krag, Aleksander
Karsdal, Morten Asser
Bay-Jensen, Anne-Christine
author_facet Mortensen, Joachim Høg
Manon-Jensen, Tina
Jensen, Michael Dam
Hägglund, Per
Klinge, Lone Gabriels
Kjeldsen, Jens
Krag, Aleksander
Karsdal, Morten Asser
Bay-Jensen, Anne-Christine
author_sort Mortensen, Joachim Høg
collection PubMed
description BACKGROUND: Increased protease activity is a key pathological feature of inflammatory bowel disease (IBD). However, the differences in extracellular matrix remodelling (ECM) in Crohn’s disease (CD) and ulcerative colitis (UC) are not well described. An increased understanding of the inflammatory processes may provide optimized disease monitoring and diagnostics. We investigated the tissue remodelling in IBD and IBS patients by using novel blood-based biomarkers reflecting ECM remodelling. METHODS: Five ECM biomarkers (VICM, BGM, EL-NE, C5M, Pro-C5) were measured by competitive ELISAs in serum from 72 CD patients, 60 UC patients, 22 patients with irritable bowel syndrome (IBS), and 24 healthy donors. One-way analysis of variance, Mann-Whitney U-test, logistic regression models, and receiver operator characteristics (ROC) curve analysis was carried out to evaluate the diagnostic accuracy of the biomarkers. RESULTS: The ECM remodelling was significantly different in UC compared to CD. The best biomarker combination to differentiate UC from CD and colonic CD was BGM and VICM (AUC = 0.98, P<0.001; AUC = 0.97, P<0.001), and the best biomarker combination to differentiate IBD from IBS patients were BGM, EL-NE, and Pro-C5 (AUC = 0.8, P<0.001). When correcting for the use of immunosuppressant and elevated CRP levels (CRP>5mg/mL), correlation of Pro-C5 (r = 0.36) with CDAI was slightly improved compared to CRP (r = 0.27) corrected for the use of immunosuppressant. Furthermore, BGM and EL-NE biomarkers were highly associated with colon inflammation in CD patients. CONCLUSION: ECM fragments of tissue remodelling in IBD affect UC and CD differently, and may aid in differentiating IBD from IBS (EL-NE, BGM, Pro-C5), and UC from CD patients (BGM, VICM). Formation of type V collagen is related to the level of inflammation in CD and may reflect disease activity in CD.
format Online
Article
Text
id pubmed-5640222
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56402222017-10-30 Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease Mortensen, Joachim Høg Manon-Jensen, Tina Jensen, Michael Dam Hägglund, Per Klinge, Lone Gabriels Kjeldsen, Jens Krag, Aleksander Karsdal, Morten Asser Bay-Jensen, Anne-Christine PLoS One Research Article BACKGROUND: Increased protease activity is a key pathological feature of inflammatory bowel disease (IBD). However, the differences in extracellular matrix remodelling (ECM) in Crohn’s disease (CD) and ulcerative colitis (UC) are not well described. An increased understanding of the inflammatory processes may provide optimized disease monitoring and diagnostics. We investigated the tissue remodelling in IBD and IBS patients by using novel blood-based biomarkers reflecting ECM remodelling. METHODS: Five ECM biomarkers (VICM, BGM, EL-NE, C5M, Pro-C5) were measured by competitive ELISAs in serum from 72 CD patients, 60 UC patients, 22 patients with irritable bowel syndrome (IBS), and 24 healthy donors. One-way analysis of variance, Mann-Whitney U-test, logistic regression models, and receiver operator characteristics (ROC) curve analysis was carried out to evaluate the diagnostic accuracy of the biomarkers. RESULTS: The ECM remodelling was significantly different in UC compared to CD. The best biomarker combination to differentiate UC from CD and colonic CD was BGM and VICM (AUC = 0.98, P<0.001; AUC = 0.97, P<0.001), and the best biomarker combination to differentiate IBD from IBS patients were BGM, EL-NE, and Pro-C5 (AUC = 0.8, P<0.001). When correcting for the use of immunosuppressant and elevated CRP levels (CRP>5mg/mL), correlation of Pro-C5 (r = 0.36) with CDAI was slightly improved compared to CRP (r = 0.27) corrected for the use of immunosuppressant. Furthermore, BGM and EL-NE biomarkers were highly associated with colon inflammation in CD patients. CONCLUSION: ECM fragments of tissue remodelling in IBD affect UC and CD differently, and may aid in differentiating IBD from IBS (EL-NE, BGM, Pro-C5), and UC from CD patients (BGM, VICM). Formation of type V collagen is related to the level of inflammation in CD and may reflect disease activity in CD. Public Library of Science 2017-10-13 /pmc/articles/PMC5640222/ /pubmed/29028807 http://dx.doi.org/10.1371/journal.pone.0185855 Text en © 2017 Mortensen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mortensen, Joachim Høg
Manon-Jensen, Tina
Jensen, Michael Dam
Hägglund, Per
Klinge, Lone Gabriels
Kjeldsen, Jens
Krag, Aleksander
Karsdal, Morten Asser
Bay-Jensen, Anne-Christine
Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title_full Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title_fullStr Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title_full_unstemmed Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title_short Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
title_sort ulcerative colitis, crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in crohn’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640222/
https://www.ncbi.nlm.nih.gov/pubmed/29028807
http://dx.doi.org/10.1371/journal.pone.0185855
work_keys_str_mv AT mortensenjoachimhøg ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT manonjensentina ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT jensenmichaeldam ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT hagglundper ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT klingelonegabriels ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT kjeldsenjens ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT kragaleksander ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT karsdalmortenasser ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease
AT bayjensenannechristine ulcerativecolitiscrohnsdiseaseandirritablebowelsyndromehavedifferentprofilesofextracellularmatrixturnoverwhichalsoreflectsdiseaseactivityincrohnsdisease